Renal side-effects of cyclo-oxygenase-type-2 inhibitor use. (Record no. 10657890)

MARC details
000 -LEADER
fixed length control field 01242 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513203742.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200003s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0140-6736
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S0140-6736(05)72163-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Stubanus, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000316
245 00 - TITLE STATEMENT
Title Renal side-effects of cyclo-oxygenase-type-2 inhibitor use.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Lancet (London, England)
Date of publication, distribution, etc. Feb 2000
300 ## - PHYSICAL DESCRIPTION
Extent 753 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comment; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Celecoxib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Creatinine
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclooxygenase Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dogs
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glomerular Filtration Rate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Renal Circulation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Riegger, G A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kammerl, M C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fischereder, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krämer, B K
773 0# - HOST ITEM ENTRY
Title Lancet (London, England)
Related parts vol. 355
-- no. 9205
-- p. 753
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S0140-6736(05)72163-2">https://doi.org/10.1016/S0140-6736(05)72163-2</a>
Public note Available from publisher's website

No items available.